Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2
diabetes mellitus (T2DM), particularly in low-and middle-income countries. To effectively …

Cardiovascular and metabolic diseases (CVMD) are the leading causes of death worldwide,
underscoring the urgent necessity to develop new pharmacotherapies. Berberine (BBR) is …

Coronary heart disease is a chronic, systemic disease with a wide range of associated
symptoms, clinical outcomes, and health care expenditure. Adverse events from coronary …

Background With the rising age of the global population, the incidence rate of cardiovascular
and cerebrovascular diseases (CCVDs) is increasing, which causes serious public health …

Adenosine is an endogenous nucleoside with a short half-life that regulates many
physiological functions involving the heart and cardiovascular system. Among the …

Cardiovascular and cerebrovascular diseases are the main cause of mortality worldwide,
currently with less than optimum therapeutic options. Danhong injection (DHI) is a medicinal …

Cardiovascular diseases (CVDs) are now the leading cause of mortality and morbidity
worldwide, resulting in a large global economic burden. Recently, complementary and …

Cardiovascular diseases (CVD) are the leading cause of death in the world. However, due
to the limited effectiveness and potential adverse effects of current treatments, the long-term …

Platelets are a heterogeneous small anucleate blood cell population with a central role both
in physiological haemostasis and in pathological states, spanning from thrombosis to …

Atherosclerosis (AS), especially atherosclerotic cardiovascular diseases (ASCVDs), and
metabolic diseases (such as diabetes, obesity, dyslipidemia, and nonalcoholic fatty liver …